mFat, uFat, nFat Therapies
Insights

mFat, uFat, nFat Therapies

London Cartilage Clinic

At London Cartilage Clinic, we offer a range of adipose tissue therapies – mFat, uFat, and nFat – each tailored to meet different regenerative medicine needs. These therapies utilise the healing potential of adipose-derived stem cells, with varying degrees of processing and application specificity.

mFat Therapy – Micro-fragmented Adipose Tissue

mFat therapy involves the processing of adipose tissue into micro-fragments. This therapy is beneficial for a broad range of regenerative treatments, offering a balance between efficacy and longevity of results.

uFat Therapy – Ultra-fragmented Adipose Tissue

uFat therapy takes adipose tissue processing a step further, creating ultra-fragmented tissue that retains a higher concentration of mesenchymal stem cells. This makes uFat particularly effective for more precise regenerative applications.

nFat Therapy – Nano-fragmented Adipose Tissue

nFat therapy represents the most refined form of adipose tissue processing, breaking down the tissue to nano-scale. This enhances the surface area for interaction, making nFat a powerful option for intensive regenerative needs, especially in osteoarthritis treatment.

Comparing mFat, uFat, and nFat Therapies

Each therapy has its unique advantages:

  • mFat: Ideal for general regenerative purposes with sustained effects.
  • uFat: Suited for more precise and delicate regenerative needs.
  • nFat: Best for aggressive and targeted therapy, particularly effective in treating osteoarthritis.

Frequently Asked Questions

  • The choice depends on your specific condition and treatment goals. mFat offers broader applications, uFat provides precise regeneration, and nFat delivers targeted, potent therapy.
  • Recovery times vary depending on the therapy and the individual’s condition. Generally, all therapies have minimal recovery times, with specifics depending on the treatment area.
  • Yes, all therapies are safe, using the patient’s own adipose tissue, minimising risks of rejection or adverse reactions. Their effectiveness varies based on the specific application and individual patient needs.

Where to go from here

A few next steps tailored to what you have just read.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.

London Cartilage Clinic

Latest Insights

Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.

ChondroFiller and Arthrosamid Dual Therapy for Knee OA
ChondroFiller / Liquid Cartilage
Eleanor Hayes

ChondroFiller and Arthrosamid Dual Therapy for Knee OA

Advanced knee osteoarthritis is not a single-tissue disorder: Grade III/IV disease simultaneously damages the articular cartilage (removing structural support) and the synovial membrane (perpetuating inflammation), leaving single-injection treatments unable to address both sites.

Can HTO Delay Knee Replacement
Knee Cartilage Repair
Eleanor Hayes

Can HTO Delay Knee Replacement

High tibial osteotomy delays or prevents total knee replacement in roughly 60–80% of appropriately selected patients by ten years. The procedure corrects varus deformity—the bow-legged misalignment concentrating destructive load on a single knee compartment—by shifting that load toward intact cartilage.

Privacy & Cookies Policy